Servicio de Reumatología, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.
Servicio de Reumatología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Reumatol Clin (Engl Ed). 2023 May;19(5):235-243. doi: 10.1016/j.reumae.2023.04.001. Epub 2023 Apr 20.
Chronic graft-versus-host disease (cGVRD) is a systemic immune-mediated complication that occurs in approximately half of the patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HCT) and, although it is associated with beneficial graft versus tumour effects and lower relapse rates, it remains the leading cause of late morbidity and mortality in these patients. The aim of this systematic review of the literature is to provide a current overview on the diagnostic musculoskeletal manifestations of cGVRD, its clinical evaluation, and therapeutic possibilities.
We ran a systematic search in PubMed, Embase, and Cochrane Library. Studies from the last 20 years were included. Priority was given to cross-sectional studies to evaluate diagnostic methods and to clinical trials in the case of articles referring to treatment. The search was limited to humans and articles published in English or Spanish.
We identified 6423 studies, of which we selected 86 (37 on clinical and diagnostic evaluation and 49 on treatments). Specific studies on fascial and joint complications are scarce and of low quality, including only isolated clinical cases or case series. Fasciitis is the most relevant musculoskeletal manifestation, and isolated joint involvement is low, sometimes unnoticed and underdiagnosed, if a thorough exploration of joint motion is not performed. Early detection of cGVRD with fascial and/or joint involvement requires careful and repeated evaluation.
The search for new biomarkers or advanced imaging techniques that allow early diagnosis is necessary. Physiotherapy is essential to improve functionality and prevent disease progression. Controlled studies are needed to establish recommendations on second lines of treatment. Because of its multisystemic nature, cGVRD requires a multidisciplinary approach.
慢性移植物抗宿主病(cGVRD)是一种系统性免疫介导的并发症,约发生于半数接受异基因造血干细胞移植(allo-HCT)的患者中。尽管其与移植物抗肿瘤效应有益及复发率降低相关,但它仍是此类患者迟发性发病率和死亡率的主要原因。本文对文献进行系统性回顾,旨在提供 cGVRD 的肌肉骨骼系统表现、临床评估和治疗选择的最新概述。
我们在 PubMed、Embase 和 Cochrane Library 中进行了系统性检索。纳入最近 20 年的研究。重点纳入了评估诊断方法的横断面研究,以及涉及治疗的临床试验。检索范围限于人类和以英文或西班牙文发表的文章。
我们共识别出 6423 项研究,其中选择了 86 项(37 项关于临床和诊断评估,49 项关于治疗)。关于筋膜和关节并发症的特定研究较少且质量较低,仅包括孤立的临床病例或病例系列。筋膜炎是最相关的肌肉骨骼表现,单独的关节受累较少,有时未被注意到且诊断不足,如果不彻底检查关节运动的话。早期发现有筋膜和/或关节受累的 cGVRD 需要仔细和反复评估。
有必要寻找新的生物标志物或先进的影像学技术以实现早期诊断。物理治疗对于改善功能和预防疾病进展至关重要。需要开展对照研究,以制定二线治疗建议。由于 cGVRD 的多系统性质,需要采用多学科方法。